Jeffrey S. Mathiesen, Chief Financial Officer at Gemphire Therapeutics Inc. (GEMP), bought 7,927 shares at $10.00 ($66K) on 2016-08-10, disclosed to the SEC on 2016-08-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.71 | 3,927 | $26K | 39.7% |
| 2 | $10.00 | 4,000 | $40K | 60.3% |
| Total | $8.37 avg | 7,927 | $66K | 100% |
| Filing → |
| ZRBA | BUY | 2008-11-17 | $3K | — | Filing → |